Flunixin Meglumine Injection USP


DIN 02240510

Veterinary Use Only


50 mg/mL flunixin (equivalent to 83 mg flunixin meglumine)

For intravenous or intramuscular use in horses, for intravenous use only in cattle and for intramuscular use only in swine.

Each milliliter of Flunazine® contains:

Active Ingredients: 50 mg flunixin (equivalent to 83 mg flunixin meglumine USP)

Non-Medicinal Ingredients: 0.1 mg edetate disodium, 2.2 mg sodium formaldehyde sulfoxylate, 4.0 mg diethanolamine, 207.2 mg propylene glycol, hydrochloric acid to adjust the pH and water for injection q.s.

Preservatives: 5.0 mg phenol

Horses: Flunazine® is recommended for the alleviation of inflammation and associated pain in musculoskeletal disorders in the horse. Flunazine® is also recommended for the alleviation of visceral pain associated with colic in the horse.

Cattle: Flunazine® is indicated for the control of pyrexia associated with Bovine Respiratory Disease (BRD), endotoxemia and acute bovine mastitis. Flunazine® is also indicated for the control of inflammation associated with endotoxemia.

Swine: Flunazine® is indicated as an aid in reducing pyrexia associated with swine respiratory disease.

Access the Compendium

For more information on Vetoquinol products and labels, please visit the Compendium website

Safety Data Sheets

To view the Vetoquinol products safety data sheets, please click here